A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors
Publication information:
Zhou, Gelot, Pantelidou, Li, Yücel, Davis R, Farkkila, Kochupurakkal, Syed, Shapiro G, Tainer J, Blagg B, Ceccaldi, D’Andrea A. A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors.
Nat Cancer. 2021;2(6):598–610.